Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Hemodynamic Effects of Bilateral and Unilateral Spinal Anesthesia Using the Continuous Pressure Recording Analytical Method.

24 agosto 2026 aggiornato da: Ayşe Temiz, Kayseri City Hospital

Comparison of the Hemodynamic Effects of Bilateral and Unilateral Spinal Anesthesia in Hip Arthroplasty Surgeries in Elderly Patients Using the Continuous Pressure Recording Analytical Method.

This randomized controlled study aims to compare the intraoperative hemodynamic effects of unilateral and bilateral spinal anesthesia in elderly patients undergoing elective total hip arthroplasty. Seventy-four patients aged 65 years and older will be randomized into two groups: unilateral spinal anesthesia (n=37) and bilateral spinal anesthesia (n=37).

Hemodynamic parameters including cardiac output, stroke volume, stroke volume variation, pulse pressure variation, and systemic vascular resistance will be continuously monitored using the Pressure Recording Analytical Method (PRAM)-based MostCare monitoring system. Intraoperative fluid requirements and vasopressor consumption will also be evaluated.

The study seeks to determine whether unilateral spinal anesthesia provides greater hemodynamic stability and reduces the need for fluid administration and vasopressor support compared with conventional bilateral spinal anesthesia in elderly patients undergoing hip arthroplasty.

Panoramica dello studio

Descrizione dettagliata

Hip arthroplasty is a commonly performed orthopedic procedure in elderly patients. Due to age-related physiological changes and the high prevalence of cardiovascular comorbidities, maintenance of intraoperative hemodynamic stability is essential in this population. Spinal anesthesia is widely used for lower extremity orthopedic surgery; however, sympathetic blockade may result in hypotension and impaired tissue perfusion, particularly in elderly patients.

Unilateral spinal anesthesia has been proposed as an alternative technique that may reduce the extent of sympathetic blockade and provide greater cardiovascular stability compared with conventional bilateral spinal anesthesia. Nevertheless, evidence regarding the advanced hemodynamic effects of these two techniques remains limited.

This prospective randomized controlled study aims to compare the hemodynamic effects of unilateral and bilateral spinal anesthesia in patients aged 65 years and older undergoing elective total hip arthroplasty. A total of 74 patients will be randomized to receive either unilateral spinal anesthesia (n=37) or bilateral spinal anesthesia (n=37).

Before spinal anesthesia, all participants will receive standard sedation with fentanyl (1-2 mcg/kg) and midazolam (0.015-0.03 mg/kg). Hemodynamic monitoring will be performed using the MostCare monitoring system based on the Pressure Recording Analytical Method (PRAM) through a radial arterial catheter.

The following hemodynamic parameters will be recorded at baseline, immediately after spinal anesthesia, and at predefined intraoperative time points: heart rate (HR), mean arterial pressure (MAP), peripheral oxygen saturation (SpO2), cardiac index (CI), stroke volume index (SVI), stroke volume variation (SVV), pulse pressure variation (PPV), systemic vascular resistance (SVR), oxygen delivery (DO2), oxygen delivery index (DO2I), maximal pressure rise during systole (dP/dtmax), cardiac cycle efficiency (CCE), and arterial elastance (Ea).

In addition, intraoperative vasopressor requirement (ephedrine use) and operative duration will be recorded and compared between study groups.

The primary objective is to determine whether unilateral spinal anesthesia provides superior hemodynamic stability compared with bilateral spinal anesthesia in elderly patients undergoing hip arthroplasty. The investigators hypothesize that unilateral spinal anesthesia will be associated with reduced hemodynamic fluctuations and lower vasopressor requirements compared with bilateral spinal anesthesia.

Tipo di studio

Interventistico

Iscrizione (Stimato)

74

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto più anziano

Accetta volontari sani

No

Descrizione

Inclusion Criteria:

  1. Adults aged 65 years and older.
  2. Patients scheduled for elective total hip arthroplasty.
  3. Patients with an American Society of Anesthesiologists (ASA) physical status classification of II, III, or IV.
  4. Patients with a Glasgow Coma Scale (GCS) score of 13-15 who are conscious and able to cooperate.
  5. Patients with suitable peripheral arterial anatomy for PRAM monitoring.
  6. Patients who provide written informed consent to participate in the study.
  7. Patients without any clinical contraindication to spinal anesthesia. -

Exclusion Criteria:

  1. Glasgow Coma Scale (GCS) score <13.
  2. Age below 65 years.
  3. History of previous major neurosurgical intervention.
  4. Anatomical abnormality, vascular defect, or infection at the site intended for arterial catheter placement for PRAM monitoring.
  5. Severe spinal deformity (e.g., severe scoliosis, previous spinal fusion surgery, or spinal trauma).
  6. Current anticoagulant therapy or coagulopathy (INR >1.5 or platelet count <75,000/mm³).
  7. Presence of skin infection or systemic infection/sepsis.
  8. Severe hypovolemia or decompensated cardiac disease in which spinal anesthesia is contraindicated.
  9. Known allergy or hypersensitivity to local anesthetics or sedative agents.
  10. Local infection or wound at the planned spinal puncture site.
  11. Clinical contraindication to spinal anesthesia (e.g., increased intracranial pressure, septicemia, or severe hypotension). -

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Altro
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Unilateral Spinal Anesthesia
Patients receive unilateral spinal anesthesia and hemodynamic parameters are monitored using the PRAM method during surgery.
Unilateral spinal anesthesia administered for unilateral lower extremity surgery.
Sperimentale: Bilateral Spinal Anesthesia
Patients receive bilateral spinal anesthesia and hemodynamic parameters are monitored using the PRAM method during surgery.
Bilateral spinal anesthesia administered for unilateral lower extremity surgery.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Cardiac Index Measured Using PRAM During Spinal Anesthesia
Lasso di tempo: From immediately before spinal anesthesia until completion of surgery, assessed at baseline and every 10 minutes for up to 180 minutes.
Cardiac index will be measured using the Pressure Recording Analytical Method (PRAM) and reported in L/min/m². Measurements recorded at each study time point will be compared between the unilateral and bilateral spinal anesthesia groups.
From immediately before spinal anesthesia until completion of surgery, assessed at baseline and every 10 minutes for up to 180 minutes.
Stroke Volume Index Measured Using PRAM During Spinal Anesthesia
Lasso di tempo: From immediately before spinal anesthesia until completion of surgery, assessed at baseline and every 10 minutes for up to 180 minutes.
Stroke volume index will be measured using the Pressure Recording Analytical Method (PRAM) and reported in mL/beat/m². Measurements recorded at each study time point will be compared between the unilateral and bilateral spinal anesthesia groups.
From immediately before spinal anesthesia until completion of surgery, assessed at baseline and every 10 minutes for up to 180 minutes.
Stroke Volume Variation Measured Using PRAM During Spinal Anesthesia
Lasso di tempo: From immediately before spinal anesthesia until completion of surgery, assessed at baseline and every 10 minutes for up to 180 minutes.
Stroke volume variation will be measured using the Pressure Recording Analytical Method (PRAM) and reported as a percentage. Measurements recorded at each study time point will be compared between the unilateral and bilateral spinal anesthesia groups.
From immediately before spinal anesthesia until completion of surgery, assessed at baseline and every 10 minutes for up to 180 minutes.
Pulse Pressure Variation Measured Using PRAM During Spinal Anesthesia
Lasso di tempo: From immediately before spinal anesthesia until completion of surgery, assessed at baseline and every 10 minutes for up to 180 minutes.
Pulse pressure variation will be measured using the Pressure Recording Analytical Method (PRAM) and reported as a percentage. Measurements recorded at each study time point will be compared between the unilateral and bilateral spinal anesthesia groups.
From immediately before spinal anesthesia until completion of surgery, assessed at baseline and every 10 minutes for up to 180 minutes.
Systemic Vascular Resistance Measured Using PRAM During Spinal Anesthesia
Lasso di tempo: From immediately before spinal anesthesia until completion of surgery, assessed at baseline and every 10 minutes for up to 180 minutes.
Systemic vascular resistance will be measured using the Pressure Recording Analytical Method (PRAM) and reported in dyn·s/cm⁵. Measurements recorded at each study time point will be compared between the unilateral and bilateral spinal anesthesia groups.
From immediately before spinal anesthesia until completion of surgery, assessed at baseline and every 10 minutes for up to 180 minutes.
Oxygen Delivery Index Measured Using PRAM During Spinal Anesthesia
Lasso di tempo: From immediately before spinal anesthesia until completion of surgery, assessed at baseline and every 10 minutes for up to 180 minutes.
Oxygen delivery index will be measured using the Pressure Recording Analytical Method (PRAM) and reported in mL/min/m². Measurements recorded at each study time point will be compared between the unilateral and bilateral spinal anesthesia groups.
From immediately before spinal anesthesia until completion of surgery, assessed at baseline and every 10 minutes for up to 180 minutes.
Arterial Elastance Measured Using PRAM During Spinal Anesthesia
Lasso di tempo: From immediately before spinal anesthesia until completion of surgery, assessed at baseline and every 10 minutes for up to 180 minutes.
Arterial elastance will be measured using the Pressure Recording Analytical Method (PRAM) and reported in mmHg/mL. Measurements recorded at each study time point will be compared between the unilateral and bilateral spinal anesthesia groups.
From immediately before spinal anesthesia until completion of surgery, assessed at baseline and every 10 minutes for up to 180 minutes.
Maximum Rate of Arterial Pressure Rise Measured Using PRAM
Lasso di tempo: From immediately before spinal anesthesia until completion of surgery, assessed at baseline and every 10 minutes for up to 180 minutes.
The maximum rate of arterial pressure rise (dP/dtmax) will be measured using the Pressure Recording Analytical Method (PRAM) and reported in mmHg/s. Measurements recorded at each study time point will be compared between the unilateral and bilateral spinal anesthesia groups.
From immediately before spinal anesthesia until completion of surgery, assessed at baseline and every 10 minutes for up to 180 minutes.
Cardiac Cycle Efficiency Measured Using PRAM
Lasso di tempo: From immediately before spinal anesthesia until completion of surgery, assessed at baseline and every 10 minutes for up to 180 minutes.
Cardiac cycle efficiency (CCE) will be measured using the Pressure Recording Analytical Method (PRAM) and reported as a dimensionless value. Measurements recorded at each study time point will be compared between the unilateral and bilateral spinal anesthesia groups.
From immediately before spinal anesthesia until completion of surgery, assessed at baseline and every 10 minutes for up to 180 minutes.
Oxygen Delivery Measured Using PRAM During Spinal Anesthesia
Lasso di tempo: From immediately before spinal anesthesia until completion of surgery, assessed at baseline and every 10 minutes for up to 180 minutes.
Oxygen delivery (DO₂) will be measured using the Pressure Recording Analytical Method (PRAM) and reported in mL/min. Measurements recorded at each study time point will be compared between the unilateral and bilateral spinal anesthesia groups.
From immediately before spinal anesthesia until completion of surgery, assessed at baseline and every 10 minutes for up to 180 minutes.
Mean Arterial Pressure During Spinal Anesthesia
Lasso di tempo: From immediately before spinal anesthesia until completion of surgery, assessed at baseline and every 10 minutes for up to 180 minutes.
Mean arterial pressure (MAP) will be measured using invasive arterial pressure monitoring and reported in mmHg. Measurements recorded at each study time point will be compared between the unilateral and bilateral spinal anesthesia groups.
From immediately before spinal anesthesia until completion of surgery, assessed at baseline and every 10 minutes for up to 180 minutes.
Heart Rate During Spinal Anesthesia
Lasso di tempo: From immediately before spinal anesthesia until completion of surgery, assessed at baseline and every 10 minutes for up to 180 minutes.
Heart rate (HR) will be recorded using standard perioperative monitoring and reported in beats per minute. Measurements recorded at each study time point will be compared between the unilateral and bilateral spinal anesthesia groups.
From immediately before spinal anesthesia until completion of surgery, assessed at baseline and every 10 minutes for up to 180 minutes.
Peripheral Oxygen Saturation During Spinal Anesthesia
Lasso di tempo: From immediately before spinal anesthesia until completion of surgery, assessed at baseline and every 10 minutes for up to 180 minutes.
Peripheral oxygen saturation (SpO₂) will be measured using pulse oximetry and reported as a percentage. Measurements recorded at each study time point will be compared between the unilateral and bilateral spinal anesthesia groups.
From immediately before spinal anesthesia until completion of surgery, assessed at baseline and every 10 minutes for up to 180 minutes.

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

1 maggio 2026

Completamento primario (Stimato)

31 agosto 2026

Completamento dello studio (Stimato)

31 agosto 2026

Date di iscrizione allo studio

Primo inviato

11 giugno 2026

Primo inviato che soddisfa i criteri di controllo qualità

24 agosto 2026

Primo Inserito (Effettivo)

27 agosto 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

27 agosto 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

24 agosto 2026

Ultimo verificato

1 giugno 2026

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi